Pathway that degrades holiday turkey fuels metastasis of triple negative breast cancer
12/16/2014
A University of Colorado Cancer Center study presented at the San Antonio Breast Cancer Symposium shows that triple negative breast cancer cells process tryptophan to promote survival while traveling...
New breast cancer classification based on epigenetics
12/16/2014
Breast cancer is the most common cancer in women. One in nine will suffer breast cancer over their lifetime.
Earlier detection could close the race gap on colon cancer deaths
12/15/2014
Racial disparities in colon cancer survival rates may be explained by overall health at the time of diagnosis rather than differences in treatment received, according to a study published in Annals...
A toddler on Tuesday peered through thick glass as Tess - the world's oldest African penguin, representing an endangered species set to vanish in the child's lifetime - dove into her pool at the...
Western University researchers uncover clues about childhood leukemia
12/15/2014
Researchers from Western University have identified a gene that has the potential to wipe out cancer cells in a common form of childhood leukemia.
FDA approves first test to confirm the presence of Human T-cell Lymphotropic Virus-I/II antibodies
12/15/2014
The U.S. Food and Drug Administration has approved MP Diagnostics HTLV Blot 2.4, the first FDA-licensed supplemental test for Human T-cell Lymphotropic Virus-I/II (HTLV-I/II).
Can a biomarker in the blood predict head fracture after traumatic brain injury?
12/15/2014
In cases of traumatic brain injury (TBI), predicting the likelihood of a cranial lesion and determining the need for head computed tomography (CT) can be aided by measuring markers of bone injury...
Massachusetts General Hospital (MGH) investigators have identified two compounds that appear, in cellular and animal models, to block the cardiac damage caused by the important chemotherapy drug...
Early trial of new drug shows promise for patients with triple-negative breast cancer
12/15/2014
In patients with metastatic triple-negative breast cancer--a disease with no approved targeted therapies--infusion of pembrolizumab produced durable responses in almost one out of five patients...
Study shows superior activity for nab-paclitaxel vs paclitxel in early breast cancer
12/15/2014
The German Breast Group (GBG) said nab-paclitaxel (ABRAXANE®) demonstrated significant benefit for patients with early high risk breast cancer when compared to conventional solvent-based...